BX Swiss - USA
626,23
|
-1,51
|
-0,24%
|
Analysen zu BX Swiss - USA-Werten
01.11.24 | Chevron Outperform | RBC Capital Markets | |
01.11.24 | Chevron Outperform | RBC Capital Markets | |
01.11.24 | Amazon Kaufen | DZ BANK | |
01.11.24 | Intel Neutral | UBS AG | |
01.11.24 | Amazon Buy | UBS AG | |
01.11.24 | Apple Neutral | UBS AG | |
01.11.24 | Amazon Buy | Goldman Sachs Group Inc. | |
01.11.24 | Amazon Outperform | RBC Capital Markets | |
01.11.24 | Amazon Buy | Jefferies & Company Inc. | |
31.10.24 | Meta Platforms Kaufen | DZ BANK | |
31.10.24 | Microsoft Buy | UBS AG | |
31.10.24 | Microsoft Kaufen | DZ BANK | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Meta Platforms Buy | Goldman Sachs Group Inc. | |
31.10.24 | Meta Platforms Buy | UBS AG | |
31.10.24 | Microsoft Overweight | JP Morgan Chase & Co. | |
31.10.24 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
31.10.24 | Amazon Buy | Jefferies & Company Inc. | |
31.10.24 | Microsoft Buy | Jefferies & Company Inc. | |
31.10.24 | Microsoft Outperform | RBC Capital Markets | |
31.10.24 | Meta Platforms Buy | Jefferies & Company Inc. | |
31.10.24 | Meta Platforms Outperform | RBC Capital Markets | |
30.10.24 | Pfizer Buy | Goldman Sachs Group Inc. | |
30.10.24 | Alphabet A Overweight | JP Morgan Chase & Co. | |
30.10.24 | Alphabet A Buy | Goldman Sachs Group Inc. | |
30.10.24 | Apple Neutral | UBS AG | |
30.10.24 | McDonald's Buy | UBS AG | |
30.10.24 | Alphabet A Neutral | UBS AG | |
30.10.24 | Boeing Outperform | RBC Capital Markets | |
30.10.24 | Alphabet A Buy | Jefferies & Company Inc. | |
30.10.24 | Alphabet A Outperform | RBC Capital Markets | |
29.10.24 | McDonald's Buy | UBS AG | |
29.10.24 | Pfizer Buy | Jefferies & Company Inc. | |
28.10.24 | Apple Hold | Jefferies & Company Inc. | |
28.10.24 | Boeing Halten | DZ BANK | |
28.10.24 | Bayer Neutral | JP Morgan Chase & Co. | |
28.10.24 | Apple Overweight | JP Morgan Chase & Co. | |
28.10.24 | Amazon Buy | UBS AG | |
25.10.24 | United Parcel Service Buy | UBS AG | |
24.10.24 | Pfizer Neutral | JP Morgan Chase & Co. |